HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Deferoxamine Mesylate

HCID 62881
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
138-14-7
Standard SMILES
CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN.CS(=O)(=O)O
InChIKey
IDDIJAWJANBQLJ-UHFFFAOYSA-N
Molecular formula
C26H52N6O11S
Average molar mass
656.8 g/mol
Monoisotopic mass
656.34147748

Overview

Deferoxamine Mesylate is the mesylate salt of an iron-chelating agent that binds free iron in a stable complex, preventing it from engaging in chemical reactions. Deferoxamine chelates iron from intra-lysosomal ferritin and ferrioxamine, a water-soluble complex excreted by the kidneys and in the feces via the bile. This agent does not readily chelate iron bound to transferrin, hemoglobin, myoglobin or cytochrome.

Names & identifiers

Preferred name
Deferoxamine Mesylate
IUPAC
N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide;methanesulfonic acid
English name
Deferoxamine mesylate
Molecular formula
C26H52N6O11S
Molecular weight
656.79

Names & synonyms

Deferoxamine mesylate138-14-7DesferalDesferrioxamine B mesylateDeferoxamine mesilateDesferrioxamine mesylateDeferoxamine methanesulfonateDesferal mesylateDeferoxamine B mesylateDESFERRIOXAMINE MESILATEDesferrioxamine methanesulfonateDTXSID6037649
Show more names
DFOMdeferoxaminebmesylateDesferioxamine mesylateDEFEROXAMINE MESYLATE SALTDeferoxamine for system suitabilityPrestwick_988DFOB (mesylate)
V9TKO7EO6KDeferoxamini mesilasNSC-756718Desferrioxamine B methanesulfonateBa-33112DTXCID4017649NSC644468CHEBI:31460

Database identifiers

CAS
138-14-7
PubChem CID
62881
DTXSID
DTXSID6037649

Properties

Computed structural properties

Topological polar surface area
269 Ų
Hydrogen bond donors
7
Hydrogen bond acceptors
12
Rotatable bonds
23
Heavy atoms
44
Formal charge
0
Complexity
832

Experimental & physicochemical properties

Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section221.4 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
148 · 148-149°
storage temp.
2 · 2-8°C
solubility
2 O: · H2O: 50 mg/mL
form
powder
color
white to off-white
Water Solubility
100 mM · Soluble to 100 mM in water
InChIKey
IDDIJAWJANBQLJ-UHFFFAOYSA-N
SMILES
C(=O)(N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN)CCC(=O)NCCCCCN(O)C(=O)C.S(=O)(=O)(O)C
FDA UNII
9 TKO7EO6K · V9TKO7EO6K
NCI Drug Dictionary
deferoxamine mesylate

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 30% (3 of 10) of reports.

Danger

H315 (60%): Causes skin irritation [Warning Skin corrosion/irritation]

P203, P233, P260, P261, P264, P264+P265, P271, P272, P280, P284, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P332+P317, P333+P317, P337+P317, P342+P316, P362+P364, P403, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 10 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory InformationDesferrioxamine B mesylate: Does not have an individual approval but may be used under an appropriate group standard
Other Safety InformationIMAP assessments - Butanediamide, N'-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxy-, monomethanesulfonate (salt): Environment tier I assessment
Hazard Classes and CategoriesSkin Irrit. 2 (60%)

Toxicology

Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Deferoxamine mesylate

vLess-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Safety data

Chemistry & industry

Pharmacology

FDA Pharmacological Classification · 2 items

DEFEROXAMINE MESYLATE

Iron Chelating Activity [MoA]; Iron Chelator [EPC]

MeSH Pharmacological ClassificationLow-molecular-weight compounds produced by microorganisms that aid in the transport and sequestration of ferric iron. (The Encyclopedia of Molecular Biology, 1994)
Applications · 3 items

DescriptionDeferoxamine is a bacterial siderophore that chelates iron. It is used to experimentally inhibit iron-dependent prolyl hydroxylases (EC50 = 17.8 μM), thus preventing the degradation of isoforms of hypoxia inducible factor during normoxia. Deferoxamine has applications in diseases that are characterized by high levels of circulating iron, such as thalassemia major.

Useschelating agent (Fe & Al)

UsesDEFEROXAMINE MESYLATE is an iron chelating agent used in therapy for patients with sickle cell diseases and iron overload. Studies suggest that it can exert potential antioxidant neuroprotective effects in stroke patients

Related reactions

18 records
New reaction record
HRID 24974 reaction equation
HRID 24974As product
HRID 24975 reaction equation
HRID 24975As product
HRID 729114 reaction equation
HRID 729114As reactant
HRID 1034376 reaction equation
HRID 1034376As solvent
HRID 1034377 reaction equation
HRID 1034377As solvent
HRID 1034378 reaction equation
HRID 1034378As solvent
HRID 1461553 reaction equation
HRID 1461553As reactant
HRID 1461554 reaction equation
HRID 1461554As reactant
PreviousPage 1 of 3

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
ChEMBL
CHEMBL1234
UNII
V9TKO7EO6K
EC Number
205-314-3
UNSPSC Code
41116107 · 41116107
NACRES
32 · NA.32
Protein binding
10 % · <10%
Excreted unchanged in urine
22 % · 22%
Volume of distribution
2 · 2-2.5(L/kg)
Biological half-life
6 · 6 / -
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
315 · H315-H319
Precautionary statements
264 · P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313
PPE
95 · Eyeshields, Gloves, type N95 (US)
Safety Statements
22 · 22-24/25
WGK Germany
2 · 2
RTECS
5310000 · UG5310000
HS Code
29280000 · 29280000
Storage Class
11 · 11 - Combustible Solids
Toxicity
16 gm/kg/34W-I · man,TDLo,parenteral,16gm/kg/34W-I (16000mg/kg),CARDIAC: PERICARDITISGASTROINTESTINAL: ULCERATION OR BLEEDING FROM SMALL INTESTINEBLOOD: OTHER CHANGES,American Journal of Kidney Diseases. Vol. 10, Pg. 71, 1987.
PPE
Eyeshields, Gloves, type N95 (US)
wgk
2
rtecs
UG5310000
hs_code
29280000
Toxicity
man,TDLo,parenteral,16gm/kg/34W-I (16000mg/kg),CARDIAC: PERICARDITISGASTROINTESTINAL: ULCERATION OR BLEEDING FROM SMALL INTESTINEBLOOD: OTHER CHANGES,American Journal of Kidney Diseases. Vol. 10, Pg. 71, 1987.
Signal word
Warning
Symbol(GHS)
GHS07
safety_code
22-24/25
Storage Class
11 - Combustible Solids
Hazard statements
H315-H319
Precautionary statements
P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313